Moolec Science (MLEC) Cash from Financing Activities (2022 - 2024)
Moolec Science's (MLEC) quarterly Cash from Financing Activities came in at -$8.9 million in Q4 2024, up 62.11% year-on-year from -$5.5 million in Q1 2024, and down 1533.11% quarter-over-quarter from -$542417.0 in Q3 2024.
Moolec Science (MLEC) Cash from Financing Activities (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Cash from Financing Activities across 3 years of filings, most recently posting -$8.9 million for Q4 2024.
- Cash from Financing Activities for Q4 2024 came in at -$8.9 million, up 62.11% year-over-year; the trailing twelve-month figure through Dec 2024 was -$15.6 million (down 136.49% YoY), and the FY2025 annual result was -$15.0 million, down 906.47% from the prior year.
- Cash from Financing Activities came in at -$8.9 million for Q4 2024 at Moolec Science, down from -$542417.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $66.2 million in Q2 2023 to a low of -$23.4 million in Q4 2023.
- The 3-year median for Cash from Financing Activities is -$334930.5 (2023), against an average of $3.5 million.
- Across the five-year window, Cash from Financing Activities surged 13144.74% in 2023 and sank 325.61% in 2024, its largest moves.
- Moolec Science's Cash from Financing Activities stood at $500000.0 in 2022, then slumped by 4775.75% to -$23.4 million in 2023, then jumped by 62.11% to -$8.9 million in 2024.
- The last three Cash from Financing Activities figures came in at -$8.9 million (Q4 2024), -$542417.0 (Q3 2024), and -$11.0 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 53,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 85,464.43 |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -8.86 Mn |
| Dec 31, 2024 | -8.86 Mn |
| Sep 30, 2024 | -542,417.00 |
| Sep 30, 2024 | -542,417.00 |
| Jun 30, 2024 | -11.00 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Dec 31, 2023 | -23.38 Mn |
| Dec 31, 2023 | -23.38 Mn |
| Sep 30, 2023 | -127,444.00 |
| Sep 30, 2023 | -127,444.00 |
| Jun 30, 2023 | 66.22 Mn |
| Jun 30, 2023 | 66.22 Mn |
| Jun 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 500,000.00 |